mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
6e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.26 |
4e-06 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |